Celgene

23 results

Brexit troubles didn’t  have a consistent impact on Irish shares on Friday. Photograph: Toby Melville/Reuters

Brexit uncertainty failed to trouble the Republic’s main share index on Friday while other European indices gained primarily due to signs of progress (...)

Earnings from one of the Iseq’s most significant component companies boosted the index by 0.76 per cent on Thursday. Photograph: Dara Mac Dónaill

Irish stocks were a bright spot among peers on Thursday as global equities declined on the back of an abrupt ending to US president Donald Trump’s mee(...)

Loxo is developing cancer treatments that target a tumors’ genetic markers regardless of where in the body they’re located

US pharma giant Eli Lilly is to buy Loxo Oncology for about $8 billion (€7 billion) in cash, the second multibillion-dollar cancer deal of the year by(...)

Apple’s first sales warning in over a decade sent European shares sliding, with the tech sector particularly badly bruised as chipmakers that supply the iPhone maker fell sharply. Photograph: Getty Images

A revenue warning from Apple rocked equity markets around the globe yesterday as concerns over a damaging China-US trade battle and its impact on worl(...)

The deal aims to create a pharmaceutical leader in cancer and immunologic disease treatments. Photograph: iStock

Bristol-Myers Squibb, the US drugmaker, has agreed to buy Celgene in a cash and stock deal valuing the rival drugmaker at roughly $90 billion includin(...)

Dr Elaine Sullivan, co-founder and chief executive of early-stage life-sciences company Carrick Therapeutics, has been chosen as The Irish Times Busin(...)

Time to sell: The  deal follows a period of upheaval at the California title. Photograph: iStock

The Los Angeles Times has been sold to the biotechnology billionaire Patrick Soon-Shiong by Tronc for $500 million (€405 million). The deal also incl(...)

US president Donald Trump signed the new tax Bill into law in December 2017. Photograph: Reuters/Jonathan Ernst

The Trump administration’s tax overhaul should accelerate major acquisitions by drug manufacturers in 2018 after a slow year for deals in 2017, accor(...)

Traders working on the floor of the New York Stock Exchange. Photograph: Michael Nagle/Bloomberg

A flurry of merger activity among European stocks drove strong moves on Monday as some regional indexes notched up new records, with investors shruggi(...)

This image, captured by a scanning electron microscope, shows T cells (orange) attached to a tumour cell. Innovative treatments harness the ability of T cells to recognize and destroy cancer cells.

An “almost miraculous” therapy for some childhood cancers is emerging; four out of five leukaemia patients have responded positively to it in recent c(...)

  • 1
  • 2
  • 3
  • Next
  • Last »